Cornercap Investment Counsel Inc Vir Biotechnology, Inc. Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 22,782 shares of VIR stock, worth $199,570. This represents 0.04% of its overall portfolio holdings.
Number of Shares
22,782
Previous 12,462
82.81%
Holding current value
$199,570
Previous $125,000
84.0%
% of portfolio
0.04%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding VIR
# of Institutions
225Shares Held
88.2MCall Options Held
177KPut Options Held
182K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$146 Million1.67% of portfolio
-
Black Rock Inc. New York, NY16.6MShares$145 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$108 Million0.0% of portfolio
-
State Street Corp Boston, MA7.07MShares$61.9 Million0.0% of portfolio
-
Baillie Gifford & CO3.95MShares$34.6 Million0.03% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.16B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...